|
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases |
1UG3NS127383-01 |
|
NINDS |
2022 |
|
Landis Award |
3R01NS101354-04S1 |
|
NINDS |
2022 |
|
Development of a nanoparticle-based gene editing technology for neurological applications |
3UH3NS115599-04S1 |
|
NINDS |
2022 |
|
Development of a nanoparticle-based gene editing technology for neurological applications |
3UH3NS115599-04S1 |
|
NINDS |
2022 |
|
Translating Genetic Risk Factors to Therapies: From Big Data to Druggable Targets |
4K00NS120365-02 |
|
NINDS |
2022 |
|
Development of a Nanoparticle-Based Gene Editing Technology for Neurological Applications |
4UH3NS115599-04 |
|
NINDS |
2022 |
|
Development of a Nanoparticle-Based Gene Editing Technology for Neurological Applications |
4UH3NS115599-04 |
|
NINDS |
2022 |
|
Research Program Award (R35 Clinical Trial Optional) - Dr. Robyn Klein NINDS |
5R35NS122310-02 |
|
NINDS |
2022 |
|
Optimization and Delivery of Bioactive Coating for High Yield and Stable Neural Recording |
5U01NS113279-04 |
|
NINDS |
2022 |
|
Optimization and Delivery of Bioactive Coating for High Yield and Stable Neural Recording |
5U01NS113279-04 |
|
NINDS |
2022 |